Literature DB >> 24246998

Contemporary management of diabetic retinopathy in Canada: from guidelines to algorithm guidance.

Philip Hooper1, Marie-Carole Boucher, Kevin Colleaux, Alan Cruess, Mark Greve, Wai-Ching Lam, Stanley Shortt, Eric Tourville.   

Abstract

Recent advances in the therapeutic options and approaches for diabetic retinopathy (DR) and diabetic macular edema (DME) have resulted in improved visual outcomes for many patients with diabetes. Yet, they have also created many clinical dilemmas for treating ophthalmologists and retina specialists, including treatment selection, initiation, frequency and duration. With this in mind, a panel of Canadian retina specialists met and discussed the current clinical evidence as well as specific situations and scenarios commonly encountered in daily practice. They also shared their experiences and therapeutic approaches. This document, containing a consensus on treatment algorithms for various clinical scenarios, is the result of their lengthy and in-depth discussions and considerations. The intent is to provide a step-by-step approach to the treatment of DR and DME. Although clinicians are encouraged to use and refer to these algorithms as a guide for various situations, they are not meant to be a replacement for sound clinical judgment.
© 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2013        PMID: 24246998     DOI: 10.1159/000354548

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  4 in total

1.  Comparison of early dexamethasone retreatment versus standard dexamethasone regimen combined with PRN ranibizumab in diabetic macular edema.

Authors:  Mücella Arıkan Yorgun; Yasin Toklu; Melek Mutlu
Journal:  Int Ophthalmol       Date:  2016-05-12       Impact factor: 2.031

2.  Short-term outcomes after the loading phase of intravitreal bevacizumab and subthreshold macular laser in non-center involved diabetic macular edema.

Authors:  Edgar Cuervo-Lozano; Jesús Hernán González-Cortés; Abraham Olvera-Barrios; Ezequiel Treviño-Cavazos; Josué Rodríguez-Pedraza; Karim Mohamed-Noriega; Jesús Mohamed-Hamsho
Journal:  Int J Ophthalmol       Date:  2018-06-18       Impact factor: 1.779

3.  Initiation of intravitreal aflibercept injection treatment in patients with diabetic macular edema: a review of VIVID-DME and VISTA-DME data.

Authors:  Focke Ziemssen; Patricio G Schlottman; Jennifer I Lim; Hansjürgen Agostini; Gabriele E Lang; Francesco Bandello
Journal:  Int J Retina Vitreous       Date:  2016-07-11

Review 4.  Evidence-based review of diabetic macular edema management: Consensus statement on Indian treatment guidelines.

Authors:  Taraprasad Das; Ajay Aurora; Jay Chhablani; Anantharaman Giridhar; Atul Kumar; Rajiv Raman; Manish Nagpal; Raja Narayanan; Sundaram Natarajan; Kim Ramasamay; Mudit Tyagi; Lalit Verma
Journal:  Indian J Ophthalmol       Date:  2016-01       Impact factor: 1.848

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.